Dr. Wenxin Xu, MD
Claim this profileDana-Farber Cancer Institute
Studies Renal Cell Carcinoma
Studies Kidney Tumors
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Wenxin Xu, MD is currently running
NK Cells + N-803
for Kidney and Bladder Cancer
The goal of this research study is to establish the safety and then to explore the effectiveness of infusing the combination of cytokine-induced memory-like (CIML) natural killer (NK) cells, a type of immune cell in the blood that is collected and bathed in special proteins to help identify and treat curtained advanced cancers, combined with low dose IL-2, which is a cytokine that activates immune cells, in advanced clear cell renal cell carcinoma and urothelial carcinoma. Names of the study therapies involved in this study are/is: * CIML NK cell therapy (a NK cell therapy) * IL-2 (a type of cytokine)
Recruiting1 award Phase < 1
IMD Drug Screening
for Kidney Cancer
This research is being done to study the safety and feasibility of implanting and retrieving a microdevice that releases microdoses of 19 specific drugs or drug combinations as a possible tool to evaluate the effectiveness of several cancer drugs against metastatic renal cell carcinoma (RCC). The name of the intervention(s) involved in this study are: * Implantable Microdevice (IMD) * Surgery (excision of tumor) * Drugs used in this study will only include drugs already used as standard of care for the treatment of metastatic renal cell carcinoma (RCC)
Recruiting1 award Phase 19 criteria
More about Wenxin Xu, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Wenxin Xu, MD has experience with
- Implantable Microdevice (IMD)
- Cytokine Induced Memory-like Natural Killer (CIML NK) Cells
- N-803
Breakdown of trials Wenxin Xu, MD has run
Renal Cell Carcinoma
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Wenxin Xu, MD specialize in?
Wenxin Xu, MD focuses on Renal Cell Carcinoma and Kidney Tumors. In particular, much of their work with Renal Cell Carcinoma has involved Stage IV patients, or patients who are undergoing treatment.
Is Wenxin Xu, MD currently recruiting for clinical trials?
Yes, Wenxin Xu, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Wenxin Xu, MD has studied deeply?
Yes, Wenxin Xu, MD has studied treatments such as Implantable Microdevice (IMD), Cytokine Induced Memory-like Natural Killer (CIML NK) Cells, N-803.
What is the best way to schedule an appointment with Wenxin Xu, MD?
Apply for one of the trials that Wenxin Xu, MD is conducting.
What is the office address of Wenxin Xu, MD?
The office of Wenxin Xu, MD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.